133 related articles for article (PubMed ID: 32162020)
1. Differentiation of borderline tumors from type I ovarian epithelial cancers on CT and MR imaging.
Yang S; Tang H; Xiao F; Zhu J; Hua T; Tang G
Abdom Radiol (NY); 2020 Oct; 45(10):3230-3238. PubMed ID: 32162020
[TBL] [Abstract][Full Text] [Related]
2. CT and MRI findings of type I and type II epithelial ovarian cancer.
Liu D; Zhang L; Indima N; Peng K; Li Q; Hua T; Tang G
Eur J Radiol; 2017 May; 90():225-233. PubMed ID: 28583639
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of the MRI features in the differentiation of benign, borderline, and malignant epithelial ovarian tumors.
Xiao F; Zhang L; Yang S; Peng K; Hua T; Tang G
J Ovarian Res; 2022 Jan; 15(1):13. PubMed ID: 35062992
[TBL] [Abstract][Full Text] [Related]
4. Multiparametric MRI for differentiation of borderline ovarian tumors from stage I malignant epithelial ovarian tumors using multivariate logistic regression analysis.
Denewar FA; Takeuchi M; Urano M; Kamishima Y; Kawai T; Takahashi N; Takeuchi M; Kobayashi S; Honda J; Shibamoto Y
Eur J Radiol; 2017 Jun; 91():116-123. PubMed ID: 28629557
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance imaging in categorization of ovarian epithelial cancer and survival analysis with focus on apparent diffusion coefficient value: correlation with Ki-67 expression and serum cancer antigen-125 level.
Zhang G; Yao W; Sun T; Liu X; Zhang P; Jin J; Bai Y; Hua K; Zhang H
J Ovarian Res; 2019 Jun; 12(1):59. PubMed ID: 31242916
[TBL] [Abstract][Full Text] [Related]
6. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Imaging].
Abdel Wahab C; Rousset P; Bolze PA; Thomassin-Naggara I
Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):260-276. PubMed ID: 32004779
[TBL] [Abstract][Full Text] [Related]
7. Is CA-125 an additional help to radiologic findings for differentiation borderline ovarian tumor from stage I carcinoma?
Lee EJ; Kim SH; Kim YH; Lee HJ
Acta Radiol; 2011 May; 52(4):458-62. PubMed ID: 21498310
[TBL] [Abstract][Full Text] [Related]
8. The enhanced T
Han X; Sun M; Wang M; Fan R; Chen D; Xie L; Liu A
Eur J Radiol; 2019 Sep; 118():187-193. PubMed ID: 31439240
[TBL] [Abstract][Full Text] [Related]
9. Are CT and MRI useful tools to distinguish between micropapillary type and typical type of ovarian serous borderline tumors?
Zhang Y; Tan J; Wang J; Ai C; Jin Y; Wang H; Li M; Zhang H; Zhong S
Abdom Radiol (NY); 2021 Jul; 46(7):3354-3364. PubMed ID: 33660041
[TBL] [Abstract][Full Text] [Related]
10. Quantitative dynamic contrast-enhanced MR imaging for differentiating benign, borderline, and malignant ovarian tumors.
Li HM; Feng F; Qiang JW; Zhang GF; Zhao SH; Ma FH; Li YA; Gu WY
Abdom Radiol (NY); 2018 Nov; 43(11):3132-3141. PubMed ID: 29556691
[TBL] [Abstract][Full Text] [Related]
11. Diffusion kurtosis imaging for differentiating borderline from malignant epithelial ovarian tumors: A correlation with Ki-67 expression.
Li HM; Zhao SH; Qiang JW; Zhang GF; Feng F; Ma FH; Li YA; Gu WY
J Magn Reson Imaging; 2017 Nov; 46(5):1499-1506. PubMed ID: 28295854
[TBL] [Abstract][Full Text] [Related]
12. MRI characteristics for differentiating mucinous borderline ovarian tumours from mucinous ovarian cancers.
Yang XY; Li X; Ma FH; Li HM; Zhao SH; Li YA; Qiang JW
Clin Radiol; 2022 Feb; 77(2):142-147. PubMed ID: 34848025
[TBL] [Abstract][Full Text] [Related]
13. Role of magnetic resonance imaging in the differentiation of mucinous ovarian carcinoma and mucinous borderline ovarian tumors.
Hasbay E; Görgülü G; Sanci M; Özamrak BG
Rev Assoc Med Bras (1992); 2023; 69(7):e20230110. PubMed ID: 37466596
[TBL] [Abstract][Full Text] [Related]
14. Borderline ovarian tumors: Guidelines from the French national college of obstetricians and gynecologists (CNGOF).
Bourdel N; Huchon C; Abdel Wahab C; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chereau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; Mathieu D'argent E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():492-501. PubMed ID: 33262005
[TBL] [Abstract][Full Text] [Related]
15. MR image-based radiomics to differentiate type Ι and type ΙΙ epithelial ovarian cancers.
Jian J; Li Y; Pickhardt PJ; Xia W; He Z; Zhang R; Zhao S; Zhao X; Cai S; Zhang J; Zhang G; Jiang J; Zhang Y; Wang K; Lin G; Feng F; Wu X; Gao X; Qiang J
Eur Radiol; 2021 Jan; 31(1):403-410. PubMed ID: 32743768
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic performance of MR imaging findings and quantitative values in the differentiation of seromucinous borderline tumour from endometriosis-related malignant ovarian tumour.
Kurata Y; Kido A; Moribata Y; Kameyama K; Himoto Y; Minamiguchi S; Konishi I; Togashi K
Eur Radiol; 2017 Apr; 27(4):1695-1703. PubMed ID: 27553934
[TBL] [Abstract][Full Text] [Related]
17. Texture Analysis of Three-Dimensional MRI Images May Differentiate Borderline and Malignant Epithelial Ovarian Tumors.
Ye R; Weng S; Li Y; Yan C; Chen J; Zhu Y; Wen L
Korean J Radiol; 2021 Jan; 22(1):106-117. PubMed ID: 32932563
[TBL] [Abstract][Full Text] [Related]
18. Role of CA125/CEA ratio and ultrasound parameters in identifying metastases to the ovaries in patients with multilocular and multilocular-solid ovarian masses.
Moro F; Pasciuto T; Djokovic D; Di Legge A; Granato V; Moruzzi MC; Mancari R; Zannoni GF; Fischerova D; Franchi D; Scambia G; Testa AC
Ultrasound Obstet Gynecol; 2019 Jan; 53(1):116-123. PubMed ID: 29978587
[TBL] [Abstract][Full Text] [Related]
19. Differentiation between endometriosis-associated ovarian cancers and non- endometriosis-associated ovarian cancers based on magnetic resonance imaging.
Zhang X; Li M; Tang Z; Li X; Song T
Br J Radiol; 2021 Sep; 94(1125):20201441. PubMed ID: 33882252
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of serum cancer antigen 125, human epididymis protein 4, ROMA, and CPH-I for diagnosis of ovarian cancer in Chinese patients with ovarian mass].
Shipeng G; Yongning C; Yadi Z; Chanyuan LI; Qifan J
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Dec; 39(12):1393-1401. PubMed ID: 31907150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]